Statistics for Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod

Total visits

views
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod 0

Total visits per month

views
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0
July 2025 0

File Visits

views
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis Focus on fingolimod.pdf 11